Advanced EGFR+ NSCLC

Advanced EGFR+ NSCLC

Treatment options will depend on your stage of cancer. Treatment also depends on your overall health, how well your lungs are doing, and other individual factors.

Your treatment team will discuss the options available to you. This can help you make an informed decision about your treatment plan.

For advanced EGFR+ NSCLC, the first preferred treatment(s) may include:

Targeted Therapy

Chemotherapy

If you do not respond well to treatment or your cancer comes back, your treatment team may consider other options including:

Targeted Therapy

Chemotherapy

Immunotherapy

Other Options

Surgery

Radiation

Clinical trials

Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Non-Small Cell Lung Cancer V.3.2025. © National Comprehensive Cancer Network, Inc. 2025. All rights reserved. Accessed January 27, 2025. To view the most recent and complete version of the guideline, go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

This site is published by Johnson & Johnson and its affiliates which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.

This information is intended for the use of patients and care partners in the United States only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States. Third party trademarks used herein are trademarks of their respective owners. Last updated April 2025.

04/25 cp-445323v2

PrivacyLegal NoticeDo Not Sell or Share My Personal InformationCookie PolicyCookies settings